Retatrutide is different because it targets multiple receptors in the body, including GLP-1, GIP, and glucagon receptors, whereas semaglutide only targets the GLP-1 receptor
Although primarily linked to cancer cachexia, recent studies have identified GDF15 as a key regulator of muscle deterioration in conditions like sarcopenia [109111]
19: Sikiric P, Gojkovic S, Krezic I, Smoday IM, Kalogjera L, Zizek H, Oroz K, Vranes H, Vukovic V, Labidi M, Strbe S, Baketic Oreskovic L, Sever M, Tepes M, Knezevic M, Barisic I, Blagaic V, Vlainic J, Dobric I, Staresinic M, Skrtic A, Jurjevic I, Boban Blagaic A, Seiwerth S
We provide the tools, education, and support you need to succeedno matter where youre starting from
Astrocyte energy and neurotransmitter metabolism in Alzheimers disease: integration of the glutamate/GABA-glutamine cycle
Presented for research literature review only Hilgenfeldt U et al